NEW YORK (GenomeWeb) – CombiMatrix today reported a 24 percent year-over-year increase in its third quarter revenues amid higher test volumes in its reproductive health segment and improved test reimbursement across all segments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.